| Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation MC Gingras, KR Covington, DK Chang, LA Donehower, AJ Gill, ... Cell reports 14 (4), 907-919, 2016 | 133 | 2016 |
| High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation C Phoomak, K Vaeteewoottacharn, A Silsirivanit, C Saengboonmee, ... Scientific reports 7 (1), 43842, 2017 | 91 | 2017 |
| High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation C Saengboonmee, W Seubwai, C Pairojkul, S Wongkham Scientific reports 6 (1), 18995, 2016 | 73 | 2016 |
| Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-ĸB C Saengboonmee, W Seubwai, U Cha'on, K Sawanyawisuth, ... Anticancer research 37 (1), 115-123, 2017 | 57 | 2017 |
| High glucose: an emerging association between diabetes mellitus and cancer progression S Supabphol, W Seubwai, S Wongkham, C Saengboonmee Journal of Molecular Medicine 99 (9), 1175-1193, 2021 | 51 | 2021 |
| Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma C Saengboonmee, W Seubwai, C Wongkham, S Wongkham Cancer epidemiology 39 (3), 274-278, 2015 | 45 | 2015 |
| Repurposing metformin for cancer treatment: a great challenge of a promising drug C Saengboonmee, T Sanlung, S Wongkham Anticancer Research 41 (12), 5913-5918, 2021 | 21 | 2021 |
| Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18: 1-h23: 0) with shorter … A Silsirivanit, C Phoomak, K Teeravirote, S Wattanavises, W Seubwai, ... Glycoconjugate Journal 36, 103-111, 2019 | 18 | 2019 |
| NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells C Saengboonmee, C Phoomak, S Supabphol, KR Covington, O Hampton, ... Life sciences 262, 118548, 2020 | 16 | 2020 |
| High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma M Detarya, S Thaenkaew, W Seubwai, S Indramanee, C Phoomak, ... Life Sciences 271, 119114, 2021 | 14 | 2021 |
| Association of diabetes mellitus and cholangiocarcinoma: update of evidence and the effects of antidiabetic medication C Saengboonmee, W Seubwai, W Lert-Itthiporn, T Sanlung, S Wongkham Canadian Journal of Diabetes 45 (3), 282-290, 2021 | 13 | 2021 |
| Prognostic biomarkers for cholangiocarcinoma and their clinical implications C Saengboonmee, K Sawanyawisuth, Y Chamgramol, S Wongkham Expert Review of Anticancer Therapy 18 (6), 579-592, 2018 | 13 | 2018 |
| Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis U Thamrongwaranggoon, M Detarya, W Seubwai, C Saengboonmee, ... Life Sciences 302, 120648, 2022 | 11 | 2022 |
| Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations S Osataphan, T Mahankasuwan, C Saengboonmee Journal of Hepato‐Biliary‐Pancreatic Sciences 28 (12), 1047-1059, 2021 | 11 | 2021 |
| Metformin as a booster of cancer immunotherapy J Panaampon, Y Zhou, C Saengboonmee International Immunopharmacology 121, 110528, 2023 | 10 | 2023 |
| Lepromatous leprosy with a suspected 30-year incubation period: A case report of a practically eradicated area N Jariyakulwong, N Julanon, C Saengboonmee Journal of Taibah University Medical Sciences 17 (4), 602-605, 2022 | 8 | 2022 |
| Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer JM Park, JM Peng, YS Shen, CY Lin, TW Hsu, YH Su, HA Chen, ... Molecular Metabolism 65, 101576, 2022 | 7 | 2022 |
| γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus C Saengboonmee, S Sorin, S Sangkhamanon, S Chomphoo, ... World Journal of Gastroenterology 29 (28), 4416, 2023 | 4 | 2023 |
| Effects of metformin on prevention and treatment of biliary tract cancer: A meta-analysis of observational studies S Supabphol, L Wattanasukchai, S Nasomjit, W Seubwai, S Wongkham, ... Gene Expression 22 (2), 115-122, 2023 | 4 | 2023 |
| Hyperglycemia alters O-GlcNAcylation patterns of hepatocytes in mice treated with hepatoxic carcinogen S Chomphoo, W Kunprom, K Thithuan, S Sorin, K Khawkhiaw, ... in vivo 37 (2), 685-695, 2023 | 4 | 2023 |
